LNWTC
RVMD icon

Laird Norton Wetherby Trust Company’s Revolution Medicines RVMD Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$760K Sell
4,060
-2,745
-40% -$401K 0.01% 587
2026
Q1 		$662K Buy
6,805
+2,076
+44% +$210K 0.01% 601
2025
Q4 		$377K Buy
+4,729
New +$310K 0.01% 811

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Laird Norton Wetherby Trust Company's RVMD Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Revolution Medicines (RVMD) stake by 40% in Q2 2026, selling an estimated $401K and leaving 4,060 shares worth $760K. The position accounts for 0.01% of the portfolio, ranked #587.

Laird Norton Wetherby Trust Company first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 4,060 shares of Revolution Medicines worth $760K as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 2,745 Revolution Medicines shares in Q2 2026, an estimated $401K.
  • Revolution Medicines made up 0.01% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #587 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.